The conformation and activity relationship of benzofuran type of angiotensin II receptor antagonists

Bioorganic and Medicinal Chemistry

Volumn 8, Issue 9, 2000, Pages 2311-2316

  Yoo, Sung Eun ^a   Kim, Soo Kyung ^a,b   Lee, Sung Hou ^a   Kim, Nak Jung ^a   Lee, Dai Woon ^b  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR; BENZOFURAN DERIVATIVE; LOSARTAN POTASSIUM; RECOMBINANT RECEPTOR; ZOLASARTAN;

ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; IN VITRO STUDY; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE; PHARMACOPHORE; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ALGORITHMS; BENZOFURANS; BINDING, COMPETITIVE; DRUG DESIGN; HUMANS; IMIDAZOLES; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0033869777     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00164-4     Document Type: Article

References (16)

1. Wexler R.R., Greenlee W.J., Irvin J.D., Goldberg M.R., Prendergast K., Smith R.D., Timmermans P.B.M.W.M. J. Med. Chem. 39:1996;625.
2. Yoo S.E., Lee S.H., Kim S.K., Lee S.H. Bioorg. Med. Chem. 5:1997;445.
3. Robertson M.J., Barnes J.C., Drew G.M., Clark K.L., Marshall F.H., Michel A., Middlemiss D., Ross B.C., Scopes D., Dowle M.D. Br. J. Pharmacol. 107:1992;1173.
4. Cramer R.D.III, Patterson D.E., Bunce J.D. J. Am. Chem. Soc. 110:1988;5959.
5. Mavromaoustakos T., Kolocouris A., Zervou M., Roumelioti P., Matsoukas J., Weisemann R. J. Med. Chem. 42:1999;1714.
6. Duncia J.V., Carini D.J., Chiu A.T., Johnson A.L., Price W.A., Wong P.C., Wexler R.R., Timmermans P.B.M.W.M. Med. Res. Rev. 12:1992;149.
7. Middlemiss D., Drew G.M., Ross B.C., Robertson M.J., Scopes D.I.C., Dowle M.D., Akers J., Cardwell K., Clark K.L., Coote S., Eldred C.D., Hamblett J., Hilditch A., Hirst G.C., Jack T., Montana J., Panchal T.A., Paton J.M.S., Shah P., Stuart G., Travers A. Bioorg. Med. Chem. Lett. 1:1991;711.
8. Middlemiss D., Watson S.P. Tetrahedron. 50:1994;13049.
9. Yoo S.E., Shin Y.A., Lee S.-H., Kim N.-J. Bioorg. Med. Chem. 3:1995;289.
10. Duncia J.V., Chiu A.T., Carini D.J., Gregory G.B., Johnson A.L., Price W.A., Wells G.J., Wong P.C., Calabrese J.C., Timmermans P.B.M.W.M. J. Med. Chem. 33:1990;1312.
11. Cheng Y., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099.
12. Clark M.D., Cramer R.D. III, Opdenbosch N.V. J. Comput. Chem. 10:1980;982.
13. Gasteiger J., Marsili M. Tetrahedron. 36:1980;3219.
14. (a) Glen, W. G.; Dunn, W. J. III; Scott, D. R. Tetrahedron Computer Methodology 1989, 2, 349.
15. (b) Stahle, L.; Wold, S. Progr. Med. Chem. 1988, 25, 292.
16. Rogers D., Hopfinger A.J. J. Chem. Inf. Comput. Sci. 34:1994;1297.